Page last updated: 2024-09-04

tipifarnib and farnesyl pyrophosphate

tipifarnib has been researched along with farnesyl pyrophosphate in 3 studies

Compound Research Comparison

Studies
(tipifarnib)
Trials
(tipifarnib)
Recent Studies (post-2010)
(tipifarnib)
Studies
(farnesyl pyrophosphate)
Trials
(farnesyl pyrophosphate)
Recent Studies (post-2010) (farnesyl pyrophosphate)
30992946961245

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Distefano, MD; Ochocki, JD1
Sánchez De Cos Escuín, J1
Beese, LS; Hast, MA; Hellinga, HW; Lubock, NB; Mabanglo, MF1

Reviews

1 review(s) available for tipifarnib and farnesyl pyrophosphate

ArticleYear
[New therapeutic targets and strategies in lung cancer].
    Archivos de bronconeumologia, 2002, Volume: 38, Issue:8

    Topics: Alkyl and Aryl Transferases; Angiogenesis Inhibitors; Antineoplastic Agents; Benzamides; Benzodiazepines; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Endothelial Growth Factors; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Erlotinib Hydrochloride; Farnesyltranstransferase; Gefitinib; Humans; Imatinib Mesylate; Imidazoles; Intercellular Signaling Peptides and Proteins; Lung Neoplasms; Lymphokines; Metalloendopeptidases; Multicenter Studies as Topic; Piperazines; Polyisoprenyl Phosphates; Protein-Tyrosine Kinases; Pyrimidines; Quinazolines; Quinolones; Randomized Controlled Trials as Topic; Receptor Protein-Tyrosine Kinases; Sesquiterpenes; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2002

Other Studies

2 other study(ies) available for tipifarnib and farnesyl pyrophosphate

ArticleYear
Prenyltransferase Inhibitors: Treating Human Ailments from Cancer to Parasitic Infections.
    MedChemComm, 2013, Volume: 4, Issue:3

    Topics:

2013
Crystal structures of the fungal pathogen Aspergillus fumigatus protein farnesyltransferase complexed with substrates and inhibitors reveal features for antifungal drug design.
    Protein science : a publication of the Protein Society, 2014, Volume: 23, Issue:3

    Topics: Antifungal Agents; Aspergillus fumigatus; Benzenesulfonamides; Catalytic Domain; Crystallography, X-Ray; Drug Design; Farnesyltranstransferase; Fungal Proteins; Humans; Peptides; Polyisoprenyl Phosphates; Protein Conformation; Protein Structure, Secondary; Protein Structure, Tertiary; Quinolones; Sesquiterpenes; Sulfonamides

2014